1. Home
  2. RBC vs NBIX Comparison

RBC vs NBIX Comparison

Compare RBC & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBC
  • NBIX
  • Stock Information
  • Founded
  • RBC 1919
  • NBIX 1992
  • Country
  • RBC United States
  • NBIX United States
  • Employees
  • RBC N/A
  • NBIX N/A
  • Industry
  • RBC Metal Fabrications
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RBC Industrials
  • NBIX Health Care
  • Exchange
  • RBC Nasdaq
  • NBIX Nasdaq
  • Market Cap
  • RBC 12.6B
  • NBIX 14.4B
  • IPO Year
  • RBC 2005
  • NBIX 1996
  • Fundamental
  • Price
  • RBC $424.62
  • NBIX $138.96
  • Analyst Decision
  • RBC Buy
  • NBIX Strong Buy
  • Analyst Count
  • RBC 6
  • NBIX 18
  • Target Price
  • RBC $441.17
  • NBIX $172.33
  • AVG Volume (30 Days)
  • RBC 204.5K
  • NBIX 1.2M
  • Earning Date
  • RBC 10-31-2025
  • NBIX 10-28-2025
  • Dividend Yield
  • RBC N/A
  • NBIX N/A
  • EPS Growth
  • RBC 19.54
  • NBIX 12.44
  • EPS
  • RBC 8.20
  • NBIX 4.19
  • Revenue
  • RBC $1,723,400,000.00
  • NBIX $2,682,700,000.00
  • Revenue This Year
  • RBC $14.28
  • NBIX $23.68
  • Revenue Next Year
  • RBC $10.86
  • NBIX $18.02
  • P/E Ratio
  • RBC $51.63
  • NBIX $33.07
  • Revenue Growth
  • RBC 8.27
  • NBIX 19.61
  • 52 Week Low
  • RBC $290.56
  • NBIX $84.23
  • 52 Week High
  • RBC $448.74
  • NBIX $157.67
  • Technical
  • Relative Strength Index (RSI)
  • RBC 55.48
  • NBIX 41.83
  • Support Level
  • RBC $420.00
  • NBIX $145.00
  • Resistance Level
  • RBC $448.74
  • NBIX $148.84
  • Average True Range (ATR)
  • RBC 12.39
  • NBIX 5.03
  • MACD
  • RBC -1.29
  • NBIX -0.99
  • Stochastic Oscillator
  • RBC 46.89
  • NBIX 10.68

About RBC RBC Bearings Incorporated

RBC Bearings Inc is an international manufacturer and marketer of engineered precision bearings, components, and essential systems for the industrial, defense, and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The company has two reportable segments: Industrial, which derives maximum revenue, and Aerospace/Defense. The Aerospace/Defense segment represents the end markets for the company's engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and the Industrial segment represents the end markets for its products used in various industrial applications. Geographically, the company generates a majority of its revenue from the United States.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: